Strategic Industry Positioning Experimur's focus on full-service toxicology testing within the pharmaceutical and biotech sectors positions it as a key partner for organizations seeking comprehensive pre-clinical support, especially those requiring GLP-compliant and animal model research.

Recent Acquisition Advantage The acquisition by Frontage Laboratories enhances Experimur's capabilities and market reach, creating opportunities for cross-selling laboratory services to a broader client base and leveraging combined industry expertise.

Innovative Collaborations Collaborations like the partnership with Silo Pharma exemplify Experimur’s involvement in cutting-edge toxicology studies, making it attractive to venture-backed firms and research organizations looking for specialized testing solutions.

Facility and Capabilities Operating from a state-of-the-art, AAALAC-Accredited, USDA-Registered facility with extensive in-house research support, Experimur can meet a wide range of complex toxicological testing needs, appealing to clients demanding high-quality and compliant research services.

Market Growth Potential With a revenue of up to $25 million and a skilled team with over 30 years of experience, Experimur is positioned to scale investments in advanced research technologies and expand client projects, offering opportunities for growth-driven sales partnerships.